Begin typing your search above and press return to search.
India Gears Up For Clinical Trial Of Ashwagandha Drugs For COVID-19
By: Tupaki Desk | 8 May 2020 10:03 AM GMT
The novel coronavirus originated from the Wuhan Province of China has spread to around 200 nations which in turn resulted in more than 3.8 lakh positive cases of the virus.
In the wake of this, many nations including India have kickstarted the process to find a potential vaccine that can fight the COVID-19 pandemic. India took a step ahead and geared up to test the Ayurvedic
Now project will be a joint venture as a collaboration of the Council of Scientific and Industrial Research (CSIR) with AYUSH, health and Science and technology Ministries with the help of Indian Council of Medical Research (ICMR),
The project will look at the efficiency of the ayurvedic drugs yashtimadhu along with ashwagandha and whether this Ayurvedic drug can work as efficiently as the hydroxychloroquine, which is cited as the anti-malaria drug.
In the wake of this, many nations including India have kickstarted the process to find a potential vaccine that can fight the COVID-19 pandemic. India took a step ahead and geared up to test the Ayurvedic
Now project will be a joint venture as a collaboration of the Council of Scientific and Industrial Research (CSIR) with AYUSH, health and Science and technology Ministries with the help of Indian Council of Medical Research (ICMR),
The project will look at the efficiency of the ayurvedic drugs yashtimadhu along with ashwagandha and whether this Ayurvedic drug can work as efficiently as the hydroxychloroquine, which is cited as the anti-malaria drug.
